Case Report: Respiratory Management With a 47-Day ECMO Support for a Critical Patient With COVID-19

Frontiers in Medicine

Xin Li¹  Bailing Li²  Yuan Gao³  Yan Xu⁴  Wen Xu⁵  Jing Wu⁵  Yuzhen Qiu⁵  Jie Huang⁵  Ying Du⁵  Ruoming Tan⁵  Shuai Qin⁵  Hongping Qu⁵  Yingchuan Li⁶  Simin Xie⁷  Feng Li⁸ 

[1] Department of Cardiovascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China;Department of Cardiovascular Surgical Intensive Care Unit (ICU), Changhai Hospital, Shanghai, China;Department of Critical Care Medicine, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China;Department of Critical Care Medicine, Ruijin Hospital North, Shanghai Jiaotong University School of Medicine, Shanghai, China;Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China;Department of Critical Care Medicine, The Sixth People's Hospital, Shanghai Jiaotong University, Shanghai, China;Department of Respiratory Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China;Intensive Care Unit, Shanghai Public Health Clinical Center, Shanghai, China;

关键词: COVID-19;    ARDS;    mechanical ventilation;    ECMO;    critical care;   

DOI  :  10.3389/fmed.2021.714387

来源: DOAJ

【 摘 要 】

This paper reports a complete case of severe acute respiratory distress syndrome (ARDS) caused by coronavirus disease 2019 (COVID-19), who presented with rapid deterioration of oxygenation during hospitalization despite escalating high-flow nasal cannulation to invasive mechanical ventilation. After inefficacy with lung-protective ventilation, positive end-expiratory pressure (PEEP) titration, prone position, we administered extracorporeal membrane oxygenation (ECMO) as a salvage respiratory support with ultra-protective ventilation for 47 days and finally discharged the patient home with a good quality of life with a Barthel Index Score of 100 after 76 days of hospitalization. The purpose of this paper is to provide a clinical reference for the management of ECMO and respiratory strategy of critical patients with COVID-19-related ARDS.

【 授权许可】

Unknown